DE2965855D1
(en)
|
1978-09-25 |
1983-08-18 |
Farlane Stuart John Mc |
Pharmaceutical preparations containing a mollusc extract
|
JP2602037B2
(ja)
|
1987-10-31 |
1997-04-23 |
持田製薬株式会社 |
1−アシル−2,3−ジヒドロ−4(1h)−キノリノン−4−オキシム誘導体、その製法およびそれらを主成分とする利尿、降圧、抗浮腫および腹水除去用医薬組成物
|
GB8814277D0
(en)
|
1988-06-16 |
1988-07-20 |
Glaxo Group Ltd |
Chemical compounds
|
JPH02264757A
(ja)
|
1989-04-06 |
1990-10-29 |
Nippon Steel Chem Co Ltd |
ニトロインドール類の製造方法
|
US5210092A
(en)
|
1990-09-25 |
1993-05-11 |
Fujisawa Pharmaceutical Co., Ltd. |
Angiotensin ii antagonizing heterocyclic derivatives
|
US5215994A
(en)
|
1990-09-25 |
1993-06-01 |
Fujisawa Pharmaceutical Co., Ltd. |
Angiotenin II antagonizing heterocyclic derivatives
|
US5354759A
(en)
|
1991-09-12 |
1994-10-11 |
Fujisawa Pharmaceutical Co., Ltd. |
Angiotenin II antagonizing heterocyclic compounds
|
WO1993006082A1
(en)
|
1991-09-13 |
1993-04-01 |
Merck & Co., Inc. |
Process for the preparation of 4-substituted-1,4-dihydropyridines
|
DE4136489A1
(de)
|
1991-11-06 |
1993-05-13 |
Bayer Ag |
Neue diethylentriamin-derivate und deren verwendung zu diagnostischen und therapeutischen zwecken
|
TW212798B
(US07981874-20110719-C00313.png)
|
1991-11-25 |
1993-09-11 |
Takeda Pharm Industry Co Ltd |
|
CA2083891A1
(en)
|
1991-12-03 |
1993-06-04 |
Angus Murray Macleod |
Heterocyclic compounds, compositions containing them and their use in therapy
|
CA2109931A1
(en)
|
1992-03-27 |
1993-10-14 |
Hiroshi Matsui |
Novel imidazole derivative, pharmaceutical use thereof, and intermediate therefor
|
JP3229654B2
(ja)
|
1992-06-05 |
2001-11-19 |
ティーディーケイ株式会社 |
有機el素子用化合物および有機el素子
|
CA2116863A1
(en)
|
1992-07-03 |
1994-01-20 |
Sumio Yokota |
Condensed heterocyclic derivatives and herbicides
|
GB2271991A
(en)
|
1992-11-02 |
1994-05-04 |
Merck Sharp & Dohme |
N-(2-oxo-1H-1,4-benzodiazepin-3-yl)-ureas
|
EP0639573A1
(de)
|
1993-08-03 |
1995-02-22 |
Hoechst Aktiengesellschaft |
Benzokondensierte 5-Ringheterocyclen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, ihre Verwendung als Diagnostikum, sowie sie enthaltendes Medikament
|
US5354763A
(en)
|
1993-11-17 |
1994-10-11 |
American Home Products Corporation |
Substituted N-heteroaryl and N-aryl-1,2-diaminocyclobutene-3,4-diones
|
AU685881B2
(en)
|
1994-02-10 |
1998-01-29 |
Pfizer Inc. |
5-heteroarylindole derivatives as benzodiazepine receptor site agonists and antagonists
|
HUT76923A
(hu)
|
1994-07-27 |
1998-01-28 |
Sankyo Company Limited |
Muszkarinreceptorokra alloszterikus hatást kifejtő heterociklusos vegyületek
|
FR2723739B1
(fr)
|
1994-08-19 |
1997-02-14 |
Sanofi Sa |
Derives de glycinamide, procedes pour leur preparation et medicaments les contenant.
|
JPH08225535A
(ja)
|
1994-11-15 |
1996-09-03 |
Dai Ichi Seiyaku Co Ltd |
インダゾール誘導体
|
EP0717143A1
(de)
|
1994-12-16 |
1996-06-19 |
Lignozym GmbH |
Mehrkomponentensystem zum Verändern, Abbau oder Bleichen von Lignin, ligninhaltigen Materialien oder ähnlichen Stoffen sowie Verfahren zu seiner Anwendung
|
ES2175079T3
(es)
|
1995-04-10 |
2002-11-16 |
Fujisawa Pharmaceutical Co |
Derivados de indol utiles como inhibidores de cgmp-pde.
|
WO1997010214A1
(fr)
|
1995-09-14 |
1997-03-20 |
Shionogi & Co., Ltd. |
Nouveaux derives d'acide phenylacetique et compositions medicinales les contenant
|
JP2000511173A
(ja)
|
1996-05-27 |
2000-08-29 |
藤沢薬品工業株式会社 |
一酸化窒素産生阻害剤としての新規なインドリルおよびベンゾフラニルカルボキサミド
|
US5629325A
(en)
|
1996-06-06 |
1997-05-13 |
Abbott Laboratories |
3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
|
US5861398A
(en)
|
1996-08-26 |
1999-01-19 |
Alanex Corporation |
Benzoperimidine-carboxylic acids and derivatives thereof
|
AU6870098A
(en)
|
1997-03-31 |
1998-10-22 |
Du Pont Merck Pharmaceutical Company, The |
Indazoles of cyclic ureas useful as hiv protease inhibitors
|
DE69837903T2
(de)
|
1997-08-11 |
2008-02-14 |
Pfizer Products Inc., Groton |
Feste pharmazeutische Dispersionen mit erhöhter Bioverfügbarkeit
|
SE9704545D0
(sv)
|
1997-12-05 |
1997-12-05 |
Astra Pharma Prod |
Novel compounds
|
SE9704544D0
(sv)
|
1997-12-05 |
1997-12-05 |
Astra Pharma Prod |
Novel compounds
|
JP2002515891A
(ja)
|
1997-12-19 |
2002-05-28 |
スミスクライン・ビーチャム・コーポレイション |
新規なピペリジン含有化合物
|
WO1999036422A1
(en)
|
1998-01-14 |
1999-07-22 |
The Uab Research Foundation |
Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof, and methods of treating bacterial and microbial infections with inhibitors of bacterial nad synthetase enzyme
|
CA2260499A1
(en)
|
1998-01-29 |
1999-07-29 |
Sumitomo Pharmaceuticals Company Limited |
Pharmaceutical compositions for the treatment of ischemic brain damage
|
WO1999043654A2
(en)
*
|
1998-02-25 |
1999-09-02 |
Genetics Institute, Inc. |
Inhibitors of phospholipase enzymes
|
CA2332279A1
(en)
|
1998-05-15 |
1999-11-25 |
Jia-He Li |
Carboxamide compounds, compositions, and methods for inhibiting parp activity
|
AU4981199A
(en)
|
1998-07-08 |
2000-02-01 |
Gregory N. Beatch |
Compositions and methods for modulating sexual activity
|
CA2336909C
(en)
|
1998-07-15 |
2009-10-20 |
Teijin Limited |
Thiobenzimidazole derivatives which are useful as inhibitors of human chymase activity
|
DE19842354A1
(de)
|
1998-09-16 |
2000-03-23 |
Bayer Ag |
Isothiazolcarbonsäureamide
|
FR2783520B1
(fr)
|
1998-09-21 |
2000-11-10 |
Oreal |
Nouveaux 4-hydroxyindoles cationiques, leur utilisation pour la teinture d'oxydation des fibres keratiniques, compositions tinctoriales et procede de teinture
|
WO2000028993A1
(en)
|
1998-11-19 |
2000-05-25 |
Nortran Pharmaceuticals, Inc. |
Serotonin ligands as pro-erectile compounds
|
AR021509A1
(es)
|
1998-12-08 |
2002-07-24 |
Lundbeck & Co As H |
Derivados de benzofurano, su preparacion y uso
|
CZ27399A3
(cs)
|
1999-01-26 |
2000-08-16 |
Ústav Experimentální Botaniky Av Čr |
Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
|
AU7962200A
(en)
|
1999-10-29 |
2001-05-14 |
Wakunaga Pharmaceutical Co., Ltd |
Novel indole derivatives and drugs containing the same as the active ingredient
|
CN1105722C
(zh)
|
1999-11-12 |
2003-04-16 |
中国科学院上海药物研究所 |
含氮杂环基的青蒿素衍生物及其制备方法
|
AU2001260081B2
(en)
|
2000-05-22 |
2005-07-28 |
Leo Pharma A/S |
Benzophenones as inhibitors of il-1beta and tnf-alpha
|
AU2001275537A1
(en)
|
2000-06-20 |
2002-01-02 |
Wayne State University |
N-and o-substituted 4-(2-(diphenylmethoxy)-ethyl)-1-((phenyl)methyl)piperidine analogs and methods of treating cns disorders therewith
|
JP2002017386A
(ja)
|
2000-07-06 |
2002-01-22 |
Mitsubishi Rayon Co Ltd |
インドール−3−カルボン酸誘導体の製造法
|
JP2002017387A
(ja)
|
2000-07-06 |
2002-01-22 |
Mitsubishi Rayon Co Ltd |
インドール誘導体の製造法
|
WO2002018363A2
(en)
|
2000-08-29 |
2002-03-07 |
Abbott Laboratories |
3-phenyl-propanoic acid derivatives as protein tyrosine phosphatase inhibitors
|
DE10046934A1
(de)
|
2000-09-21 |
2002-04-18 |
Consortium Elektrochem Ind |
Verfahren zur fermentativen Herstellung von nicht-proteinogenen L-Aminosäuren
|
AU2002212436A1
(en)
|
2000-10-25 |
2002-05-06 |
Astrazeneca Ab |
Quinazoline derivatives
|
PL204102B1
(pl)
|
2000-11-01 |
2009-12-31 |
Merck Patent Gmbh |
Zastosowanie inhibitorów αvß₃ i/lub αvß₅ do otrzymywania leku do profilaktyki i/lub terapii chorób oczu.
|
AU2002239277A1
(en)
|
2000-11-20 |
2002-05-27 |
Cor Therapeutics, Inc. |
Adenine based inhibitors of adenylyl cyclase, pharmaceutical compositions and method of use thereof
|
US6387992B1
(en)
|
2000-11-27 |
2002-05-14 |
Ciba Specialty Chemicals Corporation |
Substituted 5-heteroaryl-2-(2-hydroxyphenyl)-2h-benzotriazole UV absorbers, a process for preparation thereof and compositions stabilized therewith
|
GB0031315D0
(en)
|
2000-12-21 |
2001-02-07 |
Glaxo Group Ltd |
Indole derivatives
|
JP4094955B2
(ja)
|
2001-01-18 |
2008-06-04 |
塩野義製薬株式会社 |
置換アミノ基を有するテルフェニル化合物
|
JPWO2002057237A1
(ja)
|
2001-01-22 |
2004-05-20 |
塩野義製薬株式会社 |
置換アミノ基を有するヘテロ3環化合物
|
AU2002303084B2
(en)
|
2001-02-02 |
2006-05-25 |
Pharmacopiea, Inc. |
3,4-di-substituted cyclobutene-1, 2 -diones as CXC chemokine receptor antagonists
|
IL157253A0
(en)
|
2001-02-28 |
2004-02-19 |
Merck & Co Inc |
Acylated piperidine derivatives as melanocortin-4 receptor agonists
|
EP1377549A1
(en)
|
2001-03-12 |
2004-01-07 |
Millennium Pharmaceuticals, Inc. |
Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
|
GB0106586D0
(en)
|
2001-03-16 |
2001-05-09 |
Smithkline Beecham Plc |
Novel compounds
|
DK1818325T3
(da)
|
2001-04-16 |
2010-05-31 |
Schering Corp |
3,4-di-substituerede cyklobuten-1,2-dioner som CXC-chemokin receptorligander
|
EP1403255A4
(en)
|
2001-06-12 |
2005-04-06 |
Sumitomo Pharma |
INHIBITORS OF RHO KINASE
|
EP1844771A3
(en)
|
2001-06-20 |
2007-11-07 |
Wyeth |
Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
|
MXPA03011886A
(es)
|
2001-07-05 |
2005-03-07 |
Lundbeck & Co As H |
Piperidinias anilinicas sustituidas como antagonistas selectivos de mch.
|
CN1536998A
(zh)
|
2001-08-01 |
2004-10-13 |
Ĭ��ר������˾ |
用于治疗眼病的整联蛋白抑制剂
|
WO2003020719A1
(fr)
|
2001-09-03 |
2003-03-13 |
Takeda Chemical Industries, Ltd. |
Derives de 1,3-benzothiazinone et leur utilisation
|
MXPA04003439A
(es)
|
2001-10-12 |
2004-07-08 |
Schering Corp |
Compuestos de maleimida 3,4 disustituidos como antagonistas de receptor de quimiocina cxc.
|
FR2831536A1
(fr)
|
2001-10-26 |
2003-05-02 |
Aventis Pharma Sa |
Nouveaux derives de benzimidazoles, leur procede de preparation, leur application a titre de medicament, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de kdr
|
JP5039268B2
(ja)
|
2001-10-26 |
2012-10-03 |
アベンティス・ファーマスーティカルズ・インコーポレイテツド |
ベンゾイミダゾールおよび類縁体および蛋白キナーゼ阻害剤としてのその使用
|
CN1589269A
(zh)
|
2001-10-26 |
2005-03-02 |
康涅狄格大学 |
杂1,2-二氢化茚:一类新型有效的大麻配体
|
US20030187026A1
(en)
|
2001-12-13 |
2003-10-02 |
Qun Li |
Kinase inhibitors
|
US6933316B2
(en)
|
2001-12-13 |
2005-08-23 |
National Health Research Institutes |
Indole compounds
|
SE0104331D0
(sv)
|
2001-12-19 |
2001-12-19 |
Astrazeneca Ab |
Novel compounds
|
JP2003192716A
(ja)
|
2001-12-27 |
2003-07-09 |
Mitsui Chemicals Inc |
オレフィン重合用触媒および該触媒を用いたオレフィンの重合方法
|
PT1477472E
(pt)
|
2002-02-21 |
2009-03-17 |
Asahi Kasei Pharma Corp |
Derivado de ácido fenilalcanóico substituído e sua utilização
|
EA200400980A1
(ru)
|
2002-02-27 |
2005-02-24 |
Пфайзер Продактс Инк. |
Ингибиторы асс
|
US7125906B2
(en)
|
2002-04-03 |
2006-10-24 |
Astrazeneca Ab |
Indole derivatives having anti-angiogenetic activity
|
AU2003237790A1
(en)
|
2002-05-14 |
2003-12-02 |
Baylor College Of Medicine |
Small molecule inhibitors of her2 expression
|
WO2003099206A2
(en)
|
2002-05-21 |
2003-12-04 |
Bristol-Myers Squibb Company |
Indole compounds useful as impdh inhibitors
|
US20050261164A1
(en)
|
2002-07-09 |
2005-11-24 |
Fujisawa Pharmaceutical Co., Ltd. |
Remedy for urinary frequency and urinary incontinence
|
US6972336B2
(en)
|
2002-07-18 |
2005-12-06 |
Novartis Ag |
N-alkylation of indole derivatives
|
JP2006502133A
(ja)
|
2002-08-10 |
2006-01-19 |
アステックス、セラピューティックス、リミテッド |
サイクリン依存キナーゼ(cdk)インヒビターとしての3−(カルボニル)1h−インダゾール化合物
|
FR2845382A1
(fr)
|
2002-10-02 |
2004-04-09 |
Sanofi Synthelabo |
Derives d'indazolecarboxamides, leur preparation et leur utilisation en therapeutique
|
FR2846656B1
(fr)
|
2002-11-05 |
2004-12-24 |
Servier Lab |
Nouveaux derives d'imidazopyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
CA2507100C
(en)
|
2002-11-21 |
2012-10-09 |
Chiron Corporation |
2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
|
IS7839A
(is)
|
2002-11-22 |
2004-05-23 |
Merck Frosst Canada Ltd. |
4-oxó-1-(3-setið fenýl-1,4-díhýdró-1,8-naftýridín-3-karboxamíð fosfódíesterasa-4 hindrar
|
BRPI0315959C1
(pt)
|
2002-11-28 |
2021-05-25 |
Suven Life Sciences Ltd |
composto, composição farmacêutica, uso do composto, método para o tratamento, método para reduzir a morbidez e a mortalidade associadas com o excesso de peso e processo para a preparação do composto
|
WO2004063155A1
(en)
|
2003-01-06 |
2004-07-29 |
Eli Lilly And Company |
Fused heterocyclic derivatives as ppar modulators
|
AU2003300131A1
(en)
|
2003-01-06 |
2004-11-04 |
Eli Lilly And Company |
Indole derivatives as ppar modulators
|
CL2004000234A1
(es)
|
2003-02-12 |
2005-04-15 |
Biogen Idec Inc |
Compuestos derivados 3-(piridin-2-il)-4-heteroaril-pirazol sustituidos, antagonistas de aik5 y/o aik4; composicion farmaceutica y uso del compuesto en el tratamiento de desordenes fibroticos como esclerodermia, lupus nefritico, cicatrizacion de herid
|
ITMI20030287A1
(it)
|
2003-02-18 |
2004-08-19 |
Acraf |
Indazolammidi dotate di attivita' analgesica metodo, per
|
PT1594833E
(pt)
|
2003-02-21 |
2008-12-03 |
Chiesi Farma Spa |
Derivados do ácido 1-fenilalcanocarboxílico para o tratamento de doenças neurodegenerativas
|
JP2004284997A
(ja)
|
2003-03-24 |
2004-10-14 |
Taoka Chem Co Ltd |
高純度インドールカルボン酸類の製造方法
|
JP2004284998A
(ja)
|
2003-03-24 |
2004-10-14 |
Taoka Chem Co Ltd |
1−アルキルインドール類の製造方法
|
EP1615637A1
(en)
|
2003-04-11 |
2006-01-18 |
Novo Nordisk A/S |
Pharmaceutical use of substituted 1,2,4-triazoles
|
WO2004089415A2
(en)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
COMBINATIONS OF AN 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITOR AND A GLUCOCORTICOID RECEPTOR AGONIST
|
WO2004089896A1
(en)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ACTIVE COMPOUNDS
|
WO2004089416A2
(en)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
Combination of an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent
|
ATE455547T1
(de)
|
2003-04-11 |
2010-02-15 |
High Point Pharmaceuticals Llc |
Pharmazeutische verwendungen von kondensierten 1, 2,4-triazolen
|
WO2004089471A2
(en)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
NEW PYRAZOLO[1,5-a] PYRIMIDINES DERIVATIVES AND PHARMACEUTICAL USE THEREOF
|
WO2004099192A2
(en)
|
2003-04-30 |
2004-11-18 |
The Institutes Of Pharmaceutical Discovery, Llc |
Heterocycle substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
|
US7119205B2
(en)
|
2003-05-16 |
2006-10-10 |
Abbott Laboratories |
Thienopyridones as AMPK activators for the treatment of diabetes and obesity
|
US7429596B2
(en)
|
2003-06-20 |
2008-09-30 |
The Regents Of The University Of California |
1H-pyrrolo [2,3-D] pyrimidine derivatives and methods of use thereof
|
WO2005005411A1
(en)
|
2003-07-04 |
2005-01-20 |
Glaxosmithkline S.P.A. |
Substituted indole ligands for the orl-1 receptor
|
WO2005014554A1
(en)
|
2003-08-08 |
2005-02-17 |
Astex Therapeutics Limited |
1h-indazole-3-carboxamide compounds as mapkap kinase modulators
|
US7470807B2
(en)
|
2003-08-14 |
2008-12-30 |
Asahi Kasei Pharma Corporation |
Substituted arylalkanoic acid derivatives and use thereof
|
EP1679308B1
(en)
|
2003-10-15 |
2013-07-24 |
Ube Industries, Ltd. |
Novel indazole derivative
|
JP2005145859A
(ja)
|
2003-11-13 |
2005-06-09 |
Nippon Steel Chem Co Ltd |
脱水素化方法及び芳香族複素環化合物の製造方法
|
JP4458819B2
(ja)
|
2003-11-13 |
2010-04-28 |
株式会社リコー |
アゾ置換インドール化合物及びこれを用いた光記録媒体
|
WO2005063767A2
(en)
|
2003-12-22 |
2005-07-14 |
Memory Pharmaceuticals Corporation |
Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof
|
BRPI0508771A
(pt)
|
2004-03-25 |
2007-08-14 |
Memory Pharm Corp |
indazóis, benzotiazóis, benzoisotiazóis, benzisoxazóis, e a preparação e usos dos mesmos
|
WO2005097203A2
(en)
|
2004-04-01 |
2005-10-20 |
Cardiome Pharma Corp. |
Serum protein conjugates of ion channel modulating compounds and uses thereof
|
JP4510500B2
(ja)
|
2004-04-15 |
2010-07-21 |
株式会社リコー |
アゾ置換インドール化合物及びアゾ金属キレート化合物、並びに光記録媒体
|
US7632831B2
(en)
|
2004-05-07 |
2009-12-15 |
Memory Pharmaceuticals Corporation |
1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof
|
AP2320A
(en)
|
2004-05-12 |
2011-11-07 |
Pfizer Procucts Inc |
Proline derivatives and their use as dipeptidyl peptidase IV inhibitors.
|
AP2006003768A0
(en)
|
2004-05-25 |
2006-10-31 |
Pfizer Prod Inc |
TetraazabenzoÄeÜazulene derivatives and analogs tehereof
|
WO2005121137A1
(en)
|
2004-06-03 |
2005-12-22 |
Brandeis University |
Asymmetric michael and aldol addition using bifunctional cinchona-alkaloid-based catalysts
|
CA2570363A1
(en)
|
2004-06-18 |
2005-12-29 |
Biolipox Ab |
Indoles useful in the treatment of inflammation
|
US20080146616A1
(en)
|
2004-06-18 |
2008-06-19 |
Kristofer Olofsson |
Indoles Useful in the Treatment of Inflammation
|
EP1773771A2
(en)
|
2004-07-23 |
2007-04-18 |
Daiamed, Inc. |
Compounds and methods for treatment of thrombosis
|
WO2006010750A1
(en)
|
2004-07-28 |
2006-02-02 |
Janssen Pharmaceutica N.V. |
Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
|
US20070015771A1
(en)
|
2004-07-29 |
2007-01-18 |
Threshold Pharmaceuticals, Inc. |
Lonidamine analogs
|
JP2006045119A
(ja)
|
2004-08-04 |
2006-02-16 |
Toray Ind Inc |
ピラジン誘導体及びそれを有効成分とする腎炎治療薬
|
US20060035893A1
(en)
|
2004-08-07 |
2006-02-16 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
|
WO2006034003A2
(en)
|
2004-09-17 |
2006-03-30 |
Whitehead Institute For Biomedical Research |
Compounds, compositions and methods of inhibiting a-synuclein toxicity
|
EP1798224A1
(en)
|
2004-10-05 |
2007-06-20 |
Shionogi Co., Ltd. |
Biaryl derivative
|
CA2584248A1
(en)
|
2004-10-15 |
2006-04-27 |
Biogen Idec Ma Inc. |
Methods of treating vascular injuries
|
JP2006131519A
(ja)
|
2004-11-04 |
2006-05-25 |
Idemitsu Kosan Co Ltd |
縮合環含有化合物及びそれを用いた有機エレクトロルミネッセンス素子
|
DE102004054666A1
(de)
|
2004-11-12 |
2006-05-18 |
Bayer Cropscience Gmbh |
Substituierte Pyrazol-3-carboxamide, Verfahren zur Herstellung und Verwendung als Herbizide und Pflanzenwachstumsregulatoren
|
JPWO2006051937A1
(ja)
|
2004-11-15 |
2008-05-29 |
塩野義製薬株式会社 |
ヘテロ5員環誘導体
|
WO2006069097A2
(en)
|
2004-12-22 |
2006-06-29 |
Memory Pharmaceuticals Corporation |
Nicotinic alpha-7 receptor ligands and preparation and uses thereof
|
KR20060079121A
(ko)
|
2004-12-31 |
2006-07-05 |
에스케이케미칼주식회사 |
당뇨 및 비만 치료예방에 유효한 퀴나졸린 유도체
|
PA8660701A1
(es)
|
2005-02-04 |
2006-09-22 |
Pfizer Prod Inc |
Agonistas de pyy y sus usos
|
FR2882054B1
(fr)
|
2005-02-17 |
2007-04-13 |
Sanofi Aventis Sa |
Derives de 1,5-diarylpyrrole, leur preparation et leur application en therapeutique
|
JP5055263B2
(ja)
|
2005-03-30 |
2012-10-24 |
ダエウン ファーマシューティカル カンパニー リミテッド |
抗真菌性トリアゾール誘導体
|
WO2006110516A1
(en)
|
2005-04-11 |
2006-10-19 |
Abbott Laboratories |
Acylhydrazide p2x7 antagonists and uses thereof
|
NZ563522A
(en)
|
2005-04-22 |
2010-01-29 |
Daiichi Sankyo Co Ltd |
Heterocyclic compound with immunosuppressive activity
|
JP5794721B2
(ja)
|
2005-05-17 |
2015-10-14 |
サーコード バイオサイエンス インコーポレイテッド |
眼障害の治療のための組成物および方法
|
WO2006130437A2
(en)
|
2005-05-27 |
2006-12-07 |
Brandeis University |
Asymmetric carbon-carbon-bond-forming reactions catalyzed by bifunctional cinchona alkaloids
|
WO2006130453A1
(en)
|
2005-05-27 |
2006-12-07 |
Brandeis University |
Asymmetric aldol additions using bifunctional cinchona-alkaloid-based catalysts
|
CA2610655A1
(en)
|
2005-06-03 |
2006-12-14 |
Abbott Laboratories |
Cyclobutyl amine derivatives
|
WO2006133559A1
(en)
|
2005-06-14 |
2006-12-21 |
Merck Frosst Canada Ltd. |
Reversible inhibitors of monoamine oxidase a and b
|
WO2007002461A1
(en)
|
2005-06-23 |
2007-01-04 |
Dr. Reddy's Laboratories Ltd. |
3,4-substituted thiazoles as ampk activators
|
BRPI0612320A2
(pt)
|
2005-06-27 |
2010-11-09 |
Sanofi Aventis |
derivados de pirazolopiridina como inibidores de receptor de cinase 1 beta-adrenégico
|
CN101273022A
(zh)
|
2005-07-04 |
2008-09-24 |
雷迪博士实验室有限公司 |
作为ampk激活剂的噻唑衍生物
|
JP2007015952A
(ja)
|
2005-07-06 |
2007-01-25 |
Shionogi & Co Ltd |
ナフタレン誘導体
|
US20070203209A1
(en)
|
2005-08-18 |
2007-08-30 |
Wilmin Bartolini |
Useful indole compounds
|
EP1754483A1
(en)
|
2005-08-18 |
2007-02-21 |
Merck Sante |
Use of thienopyridone derivatives as AMPK activators and pharmaceutical compositions containing them
|
US8106066B2
(en)
|
2005-09-23 |
2012-01-31 |
Memory Pharmaceuticals Corporation |
Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
|
MX2008005662A
(es)
|
2005-11-03 |
2008-12-15 |
Ilypsa Inc |
Compuestos de azaindol y uso de los mismos como inhibidores de la fosfolipasa a2.
|
JP2009514892A
(ja)
|
2005-11-03 |
2009-04-09 |
イリプサ, インコーポレイテッド |
多価ホスホリパーゼインヒビターを含むホスホリパーゼインヒビター、および内腔に局在化されるホスホリパーゼインヒビターとしての使用を含むその使用
|
MX2008005666A
(es)
|
2005-11-03 |
2009-03-02 |
Ilypsa Inc |
Compuestos multivalentes de indol y uso de los mismos como inhibidores de fosfolipasa-a2.
|
KR20080067339A
(ko)
|
2005-11-09 |
2008-07-18 |
메모리 파마슈티칼스 코포레이션 |
1h-인다졸, 벤조티아졸, 1,2-벤조이속사졸,1,2-벤조이소티아졸, 및 크로몬 및 그들의 제조법 및 용도
|
WO2007058504A1
(en)
|
2005-11-21 |
2007-05-24 |
Lg Life Sciences, Ltd. |
Novel compounds as agonist for ppar gamma and ppar alpha, method for preparation of the same, and pharmaceutical composition containing the same
|
CN1978445B
(zh)
|
2005-12-02 |
2010-09-01 |
中国科学院上海药物研究所 |
一种可用作人源腺苷单核苷酸激活蛋白激酶激活剂的化合物及其制备方法和应用
|
WO2007070818A1
(en)
|
2005-12-14 |
2007-06-21 |
Bristol-Myers Squibb Company |
Six-membered heterocycles useful as serine protease inhibitors
|
KR20080087817A
(ko)
|
2005-12-14 |
2008-10-01 |
브리스톨-마이어스 스큅 컴퍼니 |
인자 xia 억제제로서 아릴프로피온아미드,아릴아크릴아미드, 아릴프로핀아미드 또는 아릴메틸우레아유사체
|
WO2007079173A2
(en)
|
2005-12-30 |
2007-07-12 |
Emergent Biosolutions Inc. |
Novel 2-heteroaryloxy-phenol derivatives as antibacterial agents
|
WO2007092751A2
(en)
|
2006-02-03 |
2007-08-16 |
Eli Lilly And Company |
Compounds and methods for modulating fx-receptors
|
GB0603041D0
(en)
|
2006-02-15 |
2006-03-29 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
KR20080103584A
(ko)
|
2006-03-30 |
2008-11-27 |
아사히 가세이 파마 가부시키가이샤 |
치환 이환식 환상 유도체 및 그 용도
|
EP2001480A4
(en)
|
2006-03-31 |
2011-06-15 |
Abbott Lab |
Indazole CONNECTIONS
|
EP2012778A4
(en)
|
2006-04-18 |
2011-08-10 |
Abbott Lab |
VANILLOID RECEPTOR (VR1) SUBType 1 ANTAGONISTS AND USES THEREOF
|
PT2463283E
(pt)
|
2006-04-20 |
2014-08-27 |
Pfizer Prod Inc |
Compostos heterocíclicos de fenil amido condensados para a prevenção e tratamento de doenças mediadas pela glucoquinase
|
MY147661A
(en)
|
2006-05-19 |
2012-12-31 |
Abbott Lab |
Fused bicycloheterocycle substituted azabicyclic alkane derivatives
|
WO2007140183A1
(en)
|
2006-05-24 |
2007-12-06 |
Eli Lilly And Company |
Fxr agonists
|
US8227480B2
(en)
|
2006-06-08 |
2012-07-24 |
Ube Industries, Ltd. |
Indazole derivative having spiro ring structure in side chain
|
CN101484420B
(zh)
|
2006-07-03 |
2014-04-30 |
比奥维特罗姆上市公司 |
作为5-ht6调节剂的吲哚
|
FR2903695B1
(fr)
|
2006-07-13 |
2008-10-24 |
Merck Sante Soc Par Actions Si |
Utilisation de derives d'imidazole activateurs de l'ampk, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
KR100826108B1
(ko)
|
2006-08-04 |
2008-04-29 |
한국화학연구원 |
퓨란-2-카복실산 유도체 및 그의 제조 방법
|
WO2008019357A2
(en)
|
2006-08-07 |
2008-02-14 |
Ironwood Pharmaceuticals, Inc. |
Indole compounds
|
JP2008063278A
(ja)
|
2006-09-07 |
2008-03-21 |
Fujifilm Finechemicals Co Ltd |
1−ピリジン−4−イル−インドール類の製造方法
|
JP2008106037A
(ja)
|
2006-09-29 |
2008-05-08 |
Osaka Prefecture Univ |
インドール化合物の製造方法およびインドール化合物
|
WO2008054748A2
(en)
|
2006-10-31 |
2008-05-08 |
Arena Pharmaceuticals, Inc. |
Indazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
|
CA2670422C
(en)
|
2006-11-29 |
2011-09-06 |
Pfizer Products Inc. |
Spiroketone acetyl-coa carboxylase inhibitors
|
CA2671543A1
(en)
|
2006-12-05 |
2008-06-12 |
Chung-Ming Sun |
Indazole compounds
|
WO2008072850A1
(en)
|
2006-12-11 |
2008-06-19 |
Amorepacific Corporation |
Triazine derivatives having inhibitory activity against acetyl-coa carboxylase
|
WO2008071451A1
(en)
|
2006-12-14 |
2008-06-19 |
Bayer Schering Pharma Aktiengesellschaft |
Dihydropyridine derivatives useful as protein kinase inhibitors
|
WO2011028195A2
(en)
|
2006-12-18 |
2011-03-10 |
Ambrx, Inc. |
Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
|
EP2094681A1
(en)
|
2006-12-22 |
2009-09-02 |
Novartis AG |
Indol-4-yl-pyrimidinyl-2-yl-amine derivatives and use thereof as cyclin dependant kinase inhibitors
|
EP2079694B1
(en)
|
2006-12-28 |
2017-03-01 |
Rigel Pharmaceuticals, Inc. |
N-substituted-heterocycloalkyloxybenzamide compounds and methods of use
|
PE20081559A1
(es)
|
2007-01-12 |
2008-11-20 |
Merck & Co Inc |
DERIVADOS DE ESPIROCROMANONA SUSTITUIDOS COMO INHIBIDORES DE ACETIL CoA CARBOXILASA
|
EP2120952A4
(en)
|
2007-01-15 |
2011-09-21 |
Us Of America As Represented By The Secretary Of The Army On Behalf Of The U S Army Res Inst Of Infe |
ANTIVIRAL COMPOUNDS AND METHOD FOR THEIR USE
|
DE102007002717A1
(de)
|
2007-01-18 |
2008-07-24 |
Merck Patent Gmbh |
Heterocyclische Indazolderivate
|
JP2008179567A
(ja)
|
2007-01-25 |
2008-08-07 |
Toray Ind Inc |
ピラジン誘導体を有効成分とする抗がん剤
|
AR065093A1
(es)
|
2007-02-05 |
2009-05-13 |
Merck Frosst Canada Ltd |
Compuestos farmacéuticos inhibidores de la biosintesis de leucotrienos
|
CA2676906A1
(en)
|
2007-02-12 |
2008-08-21 |
Intermune, Inc. |
Novel inhibitors hepatitis c virus replication
|
JP5107589B2
(ja)
|
2007-02-13 |
2012-12-26 |
旭化成株式会社 |
インドール誘導体
|
JP2008208074A
(ja)
|
2007-02-27 |
2008-09-11 |
Toray Ind Inc |
ピラジン誘導体を有効成分とする抗がん剤
|
JP2008222576A
(ja)
|
2007-03-09 |
2008-09-25 |
Japan Enviro Chemicals Ltd |
インドール化合物の製造方法
|
WO2008110863A1
(en)
|
2007-03-15 |
2008-09-18 |
Glenmark Pharmaceuticals S.A. |
Indazole derivatives and their use as vanilloid receptor ligands
|
WO2008118822A1
(en)
|
2007-03-23 |
2008-10-02 |
Rigel Pharmaceuticals, Inc. |
Compositions and methods for inhibition of the jak pathway
|
WO2008116910A1
(en)
|
2007-03-28 |
2008-10-02 |
Neurosearch A/S |
Purinyl derivatives and their use as potassium channel modulators
|
WO2008136642A1
(en)
|
2007-05-07 |
2008-11-13 |
Mazence Inc. |
Naphthoquinone-based pharmaceutical composition for treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases
|
WO2008150899A1
(en)
|
2007-05-29 |
2008-12-11 |
Emory University |
Combination therapies for treatment of cancer and inflammatory diseases
|
FR2917735B1
(fr)
|
2007-06-21 |
2009-09-04 |
Sanofi Aventis Sa |
Nouveaux indazoles substitutes, leur preparation et leur utilisation en therapeutique
|
TW200906823A
(en)
|
2007-07-16 |
2009-02-16 |
Lilly Co Eli |
Compounds and methods for modulating FXR
|
US20090036425A1
(en)
|
2007-08-02 |
2009-02-05 |
Pfizer Inc |
Substituted bicyclolactam compounds
|
WO2009019446A1
(en)
|
2007-08-03 |
2009-02-12 |
Betagenon Ab |
Compounds useful as medicaments
|
KR20090016804A
(ko)
|
2007-08-13 |
2009-02-18 |
주식회사 티지 바이오텍 |
신규 벤질에스테르계 화합물 및 이를 유효성분으로함유하는 비만, 당뇨 및 고지혈증의 예방 및 치료용 조성물
|
WO2009026107A1
(en)
|
2007-08-17 |
2009-02-26 |
Portola Pharmaceuticals, Inc. |
Protein kinase inhibitors
|
TW200924751A
(en)
|
2007-08-29 |
2009-06-16 |
Schering Corp |
2,3-substituted indole derivatives and methods of use thereof
|
KR20100067652A
(ko)
|
2007-08-29 |
2010-06-21 |
쉐링 코포레이션 |
치환된 인돌 유도체 및 이의 사용방법
|
US8415358B2
(en)
|
2007-09-17 |
2013-04-09 |
Neurosearch A/S |
Pyrazine derivatives and their use as potassium channel modulators
|
ES2448870T3
(es)
|
2007-10-26 |
2014-03-17 |
Janssen Pharmaceutica, N.V. |
Derivados de quinolina como inhibidores de PARP
|
US20090124680A1
(en)
|
2007-10-31 |
2009-05-14 |
Mazence Inc. |
Use of prodrug composition containing naphthoquinone-based compound for manufacture of medicament for treatment or prevention of diseases involving metabolic syndrome
|
ES2552733T3
(es)
|
2007-11-16 |
2015-12-01 |
Rigel Pharmaceuticals, Inc. |
Compuestos de carboxamida, sulfonamida y amina para trastornos metabólicos
|
CN102317285A
(zh)
|
2007-11-16 |
2012-01-11 |
先灵公司 |
3-氨基磺酰基取代的吲哚衍生物及其使用方法
|
WO2009084695A1
(ja)
|
2007-12-28 |
2009-07-09 |
Carna Biosciences Inc. |
2-アミノキナゾリン誘導体
|
US8469654B2
(en)
|
2008-01-31 |
2013-06-25 |
National University Corporation Yokohama National University |
Fluid machine
|
BRPI0905952A2
(pt)
|
2008-02-04 |
2015-06-30 |
Mercury Therapeutics |
Composto e sais do mesmo e compição farmacêutica
|
WO2009115874A2
(en)
|
2008-03-17 |
2009-09-24 |
Matrix Laboratories Ltd. |
Novel heterocyclic compounds, pharmaceutical compositions containing them and processes for their preparation
|
AU2009226868A1
(en)
|
2008-03-20 |
2009-09-24 |
F. Hoffmann-La Roche Ag |
Pyrrolidinyl derivatives and uses thereof
|
WO2009120783A1
(en)
|
2008-03-25 |
2009-10-01 |
The Johns Hopkins University |
High affinity inhibitors of hepatitis c virus ns3/4a protease
|
JP5564033B2
(ja)
|
2008-03-27 |
2014-07-30 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
ヒストンデアセチラーゼの新規インヒビターとしてのアザ−ビシクロヘキシル置換インドリルアルキルアミノ誘導体
|
US8563729B2
(en)
|
2008-04-11 |
2013-10-22 |
Merck Patent Gmbh |
Thienopyridone derivatives as AMP-activated protein kinase (AMPK) activators
|
US8314107B2
(en)
|
2008-04-23 |
2012-11-20 |
Rigel Pharmaceuticals, Inc. |
Carboxamide compounds and methods for using the same
|
MY160357A
(en)
|
2008-05-05 |
2017-02-28 |
Merck Patent Gmbh |
Thienopyridone derivatives as amp-activated protein kinase (ampk) activators
|
GB0808282D0
(en)
|
2008-05-07 |
2008-06-11 |
Medical Res Council |
Compounds for use in stabilizing p53 mutants
|
JP5435592B2
(ja)
|
2008-05-28 |
2014-03-05 |
ファイザー・インク |
ピラゾロスピロケトンアセチルCoAカルボキシラーゼ阻害剤
|
JP2011521940A
(ja)
|
2008-05-28 |
2011-07-28 |
ファイザー・インク |
ピラゾロスピロケトンアセチルCoAカルボキシラーゼ阻害剤
|
JP5596676B2
(ja)
|
2008-06-16 |
2014-09-24 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
キノキサリンジオン誘導体
|
AR072184A1
(es)
|
2008-06-20 |
2010-08-11 |
Glaxo Group Ltd |
Derivados de oxadiazol como agonistas del receptor s1p1
|
DE102008031480A1
(de)
|
2008-07-03 |
2010-01-07 |
Merck Patent Gmbh |
Salze enthaltend ein Pyrimidincarbonsäure-Derivat
|
WO2010009190A1
(en)
|
2008-07-16 |
2010-01-21 |
King Pharmaceuticals Research And Development, Inc. |
Methods of treating atherosclerosis
|
WO2010010186A1
(en)
|
2008-07-25 |
2010-01-28 |
Galapagos Nv |
Novel compounds useful for the treatment of degenerative and inflammatory diseases
|
WO2010013161A1
(en)
|
2008-07-29 |
2010-02-04 |
Pfizer Inc. |
Fluorinated heteroaryls
|
ES2380408T3
(es)
|
2008-08-28 |
2012-05-11 |
Pfizer Inc. |
Derivados de dioxa-biciclo[3.2.1]octano-2,3,4-triol
|
WO2010036910A1
(en)
|
2008-09-26 |
2010-04-01 |
Yoshikazu Ohta |
Heart protection by administering an amp-activated protein kinase activator
|
BRPI0920513A2
(pt)
|
2008-09-26 |
2019-09-24 |
F Hoffamann La Roche Ag |
derivados de pirina ou pirazina para tratar hcv
|
WO2010047982A1
(en)
|
2008-10-22 |
2010-04-29 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
JP2012507530A
(ja)
|
2008-10-29 |
2012-03-29 |
メルク・シャープ・エンド・ドーム・コーポレイション |
有用な抗糖尿病剤である新規な環状ベンズイミダゾール誘導体
|
JP5557845B2
(ja)
|
2008-10-31 |
2014-07-23 |
メルク・シャープ・アンド・ドーム・コーポレーション |
糖尿病用剤として有用な新規環状ベンゾイミダゾール誘導体
|
WO2010056041A2
(ko)
|
2008-11-13 |
2010-05-20 |
주식회사 머젠스 |
허혈 또는 허혈 재관류에 의해 유발되는 심장질환의 치료 및 예방을 위한 약제 조성물
|
JP5621148B2
(ja)
|
2008-11-21 |
2014-11-05 |
ラクオリア創薬株式会社 |
5−ht2b受容体拮抗活性を有する新規ピラゾール−3−カルボキサミド誘導体
|
KR101061599B1
(ko)
|
2008-12-05 |
2011-09-02 |
한국과학기술연구원 |
비정상 세포 성장 질환의 치료를 위한 단백질 키나아제 저해제인 신규 인다졸 유도체, 이의 약학적으로 허용가능한염 및 이를 유효성분으로 함유하는 약학적 조성물
|
WO2010068287A2
(en)
|
2008-12-11 |
2010-06-17 |
Angion Biomedica Corp. |
Small molecule modulators of hepatocyte growth factor (scatter factor) activity
|
ES2543205T3
(es)
|
2008-12-18 |
2015-08-17 |
Merck Serono S.A. |
Derivados heteroácidos funcionales de oxidiazol
|
JP2012513481A
(ja)
|
2008-12-23 |
2012-06-14 |
プレジデント アンド フェロウズ オブ ハーバード カレッジ |
ネクロトーシスの小分子阻害剤
|
WO2010073011A2
(en)
|
2008-12-23 |
2010-07-01 |
Betagenon Ab |
Compounds useful as medicaments
|
MX2011007639A
(es)
|
2009-01-28 |
2011-09-15 |
Rigel Pharmaceuticals Inc |
Compuestos de carboxamida y metodos para usar los mismos.
|
WO2010086613A1
(en)
|
2009-01-30 |
2010-08-05 |
Betagenon Ab |
Compounds useful as inhibitors as ampk
|
TW201038580A
(en)
|
2009-02-02 |
2010-11-01 |
Pfizer |
4-amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl derivatives
|
US20100210682A1
(en)
|
2009-02-19 |
2010-08-19 |
Abbott Laboratories |
Repeated Dosing of TRPV1 Antagonists
|
PE20120668A1
(es)
|
2009-03-11 |
2012-06-01 |
Pfizer |
Un compuesto n,n-dimetil-5-(2-metil-6-((5-metilpirazin-2-il)carbamoil)benzofuran-4-iloxi)pirimidin-carboxamida como activador de glucocinasa
|
CA2754685A1
(en)
|
2009-03-11 |
2010-09-16 |
Pfizer Inc. |
Substituted indazole amides
|
JP2012520868A
(ja)
|
2009-03-20 |
2012-09-10 |
ファイザー・インク |
3−オキサ−7−アザビシクロ[3.3.1]ノナン
|
WO2010110782A1
(en)
|
2009-03-24 |
2010-09-30 |
Sumitomo Chemical Company, Limited |
Method for manufacturing a boronic acid ester compound
|
CN102378753B
(zh)
|
2009-03-31 |
2016-03-02 |
肾脏科学股份有限公司 |
纤溶酶原激活物抑制因子-1抑制剂
|
WO2010118009A1
(en)
|
2009-04-06 |
2010-10-14 |
Ptc Therapeutics, Inc. |
Hcv inhibitor and therapeutic agent combinations
|
WO2010128425A1
(en)
|
2009-05-08 |
2010-11-11 |
Pfizer Inc. |
Gpr 119 modulators
|
WO2010128414A1
(en)
|
2009-05-08 |
2010-11-11 |
Pfizer Inc. |
Gpr 119 modulators
|
KR20120061063A
(ko)
|
2009-06-05 |
2012-06-12 |
화이자 인코포레이티드 |
Gpr 119 조절제로서의 l-(피페리딘-4-일)-피라졸 유도체
|
ES2567753T3
(es)
|
2009-07-08 |
2016-04-26 |
Baltic Bio Ab |
Derivados de 1,2,4-tiazolidin-3-ona y su uso en el tratamiento del cáncer
|
WO2011005611A1
(en)
|
2009-07-09 |
2011-01-13 |
Merck Sharp & Dohme Corp. |
Neuromedin u receptor agonists and uses thereof
|
CN102574787B
(zh)
|
2009-07-30 |
2014-12-31 |
新加坡国立大学 |
具有潜在的抗癌活性的小分子异戊二烯基半胱氨酸羧基甲基转移酶抑制剂
|
GB0915892D0
(en)
|
2009-09-10 |
2009-10-14 |
Smithkline Beecham Corp |
Compounds
|
WO2011032320A1
(en)
|
2009-09-21 |
2011-03-24 |
F. Hoffmann-La Roche Ag |
Novel alkene oxindole derivatives
|
WO2011069298A1
(en)
|
2009-12-11 |
2011-06-16 |
F. Hoffmann-La Roche Ag |
Novel cyclopropane indolinone derivatives
|
JP2013047189A
(ja)
|
2009-12-25 |
2013-03-07 |
Kyorin Pharmaceutical Co Ltd |
新規パラバン酸誘導体及びそれらを有効成分とする医薬
|
BR112012016330B8
(pt)
|
2009-12-29 |
2021-05-25 |
Poxel |
ativadores de tieno [2, 3-b] piridinadiona de ampk e composição farmacêutica compreendendo os mesmos
|
EP2538784B1
(en)
|
2010-02-25 |
2015-09-09 |
Merck Sharp & Dohme Corp. |
Benzimidazole derivatives useful anti-diabetic agents
|
US8796254B2
(en)
|
2010-03-31 |
2014-08-05 |
Rigel Pharmaceuticals, Inc. |
Methods for using carboxamide, sulfonamide and amine compounds
|
US8344137B2
(en)
|
2010-04-14 |
2013-01-01 |
Hoffman-La Roche Inc. |
3,3-dimethyl tetrahydroquinoline derivatives
|
WO2011138307A1
(en)
|
2010-05-05 |
2011-11-10 |
Glaxosmithkline Llc |
Pyrrolo [3, 2 -d] pyrimidin-3 -yl derivatives used as activators of ampk
|
US8592594B2
(en)
|
2010-07-02 |
2013-11-26 |
Hoffmann-La Roche Inc. |
Tetrahydro-quinoline derivatives
|
JP5889895B2
(ja)
|
2010-07-29 |
2016-03-22 |
ライジェル ファーマシューティカルズ, インコーポレイテッド |
Ampk活性化複素環化合物およびその使用方法
|
KR101190141B1
(ko)
|
2010-08-24 |
2012-10-12 |
서울대학교산학협력단 |
Ampk를 활성화시키는 화합물을 함유하는 약학조성물
|
JP2013230986A
(ja)
|
2010-08-25 |
2013-11-14 |
Kyorin Pharmaceutical Co Ltd |
新規ヒダントイン誘導体及びそれらを有効成分とする医薬
|
WO2012027548A1
(en)
|
2010-08-25 |
2012-03-01 |
The Feinstein Institute For Medical Research |
Compounds and methods for prevention and treatment of alzheimer's and other diseases
|
EP2617722B1
(en)
|
2010-09-10 |
2016-03-23 |
Shionogi & Co., Ltd. |
Hetero ring-fused imidazole derivative having ampk activating effect
|
WO2012040499A2
(en)
|
2010-09-22 |
2012-03-29 |
Surface Logix, Inc. |
Metabolic inhibitors
|
US8546427B2
(en)
|
2010-10-20 |
2013-10-01 |
Hoffmann-La Roche Inc. |
Tetrahydroquinoline derivatives
|
US8809369B2
(en)
|
2011-01-26 |
2014-08-19 |
Hoffmann-La Roche Inc. |
Tetrahydroquinoline derivatives
|
EP2677869B1
(en)
|
2011-02-25 |
2017-11-08 |
Merck Sharp & Dohme Corp. |
Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
|
CA2830706A1
(en)
|
2011-03-07 |
2012-09-13 |
Glaxosmithkline Llc |
Quinolinone derivatives
|
EP2683720A1
(en)
|
2011-03-07 |
2014-01-15 |
GlaxoSmithKline LLC |
1H-PYROLLO[3,2-d]PYRIMIDINEDIONE DERIVATIVES
|
KR20140047160A
(ko)
|
2011-08-12 |
2014-04-21 |
에프. 호프만-라 로슈 아게 |
인다졸 화합물, 조성물 및 사용 방법
|
AU2013224302B2
(en)
|
2012-02-21 |
2017-03-30 |
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. |
1H-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors
|